Bedaquiline trial
Indication: Multi-drug resistant tuberculosis (MDR-TB)
Population pharmacokinetic simulator for bedaquiline and its M2 metabolite in TB patients. Bedaquiline is a diarylquinoline that inhibits mycobacterial ATP synthase, approved for multi-drug resistant tuberculosis (MDR-TB). Simulate parent and metabolite concentrations across doses and patient covariates.
Drug Overview
Clinical Context
- Molecular Target
- Mycobacterial ATP synthase
- Drug Class
- Diarylquinoline antimycobacterial
- Therapeutic Area
- Infectious Disease - Tuberculosis
- Indication
- Multi-drug resistant tuberculosis (MDR-TB)
- Route of Administration
- Oral
Model Information
- Model Type
- PopPK
This simulator was built from published pharmacometric literature using PKPDBuilder's AI-powered model extraction pipeline.
About This Simulator
This interactive pharmacokinetic simulator for Bedaquiline trial allows you to explore concentration-time profiles under different dosing scenarios. The underlying PopPK model characterizes the pharmacokinetics of this diarylquinoline antimycobacterial following oral administration.
Use the simulator to visualize key exposure metrics including AUC (area under the curve), Cmax (peak concentration), and Ctrough (trough concentration).
Built with PKPDBuilder — an AI-powered platform that transforms published pharmacometric literature into interactive, deployable Shiny applications. No coding required.
Frequently Asked Questions
What is the Bedaquiline trial PK simulator?
This is a free, interactive pharmacokinetic simulator for Bedaquiline trial used in Multi-drug resistant tuberculosis (MDR-TB). It allows researchers, pharmacologists, and students to explore concentration-time profiles, dosing regimens, and exposure metrics based on published population PK models.
What drug class does Bedaquiline trial belong to?
Bedaquiline trial is classified as a Diarylquinoline antimycobacterial that targets Mycobacterial ATP synthase. It is used in the Infectious Disease - Tuberculosis therapeutic area.
What route of administration does this model simulate?
This simulator models Oral administration of Bedaquiline trial. The pharmacokinetic parameters (absorption rate, bioavailability, volume of distribution) are specific to this route.
What type of PK model is used?
This simulator uses a PopPK model. Population PK models account for interindividual variability and covariate effects on drug exposure.
Is this simulator free to use?
Yes, all PKPDBuilder simulators are completely free. They are built from published pharmacokinetic literature and are intended for research and educational purposes. No login is required to run simulations.
Can I use this for clinical dosing decisions?
No. This simulator is for research and educational purposes only. It should not be used for clinical decision-making or patient dosing. Always consult the prescribing information and clinical pharmacology guidelines for therapeutic drug use.
Related Simulators
Ready to Simulate?
Launch the Bedaquiline trial simulator to explore dosing scenarios and pharmacokinetic profiles interactively.
🚀 Launch SimulatorComments
⚠️ Disclaimer
This simulator is for research and educational purposes only. It is not intended for clinical decision-making, patient dosing, or therapeutic drug monitoring. Pharmacokinetic parameters are derived from published literature and represent population-level estimates. Individual patient pharmacokinetics may differ significantly. Always consult approved prescribing information and qualified healthcare professionals for clinical decisions.
Powered by PKPDBuilder.com • Free pharmacokinetic simulators for the scientific community